Sa. Waterman et al., EFFECT OF LAMBERT-EATON MYASTHENIC SYNDROME ANTIBODIES ON AUTONOMIC NEURONS IN THE MOUSE, Annals of neurology, 42(2), 1997, pp. 147-156
Somatic muscle weakness and autonomic symptoms characterize the autoim
mune Lambert-Eaton myasthenic syndrome (LEMS). The former results from
IgG autoantibody-mediated down-regulation of P/Q-type voltage-gated c
alcium channels at motor nerve terminals and consequent reduction in a
cetylcholine release; the basis for the autonomic symptoms is unknown.
Using omega-conocoxins GVIA and MVIIC and omega-agatoxin IVA that blo
ck N-, Q-, and P-type channels, we investigated ex vivo the calcium ch
annels subserving transmitter release from postganglionic parasympathe
tic neurons in the bladder and from postganglionic sympathetic neurons
in the vas deferens of mice injected with IgG from LEMS patients or f
rom controls. Calcium influx through N-, P-, and Q-type channels subse
rved transmitter release from parasympathetic and sympathetic neurons
in control mice. In test mice, the component of transmitter release su
bserved by P-type channels was abolished by four of four LEMS IgG prep
arations, that subserved by Q-type channels was significantly reduced
by three, and that subserved by N-type channels by one. Thus, LEMS IgG
impairs transmitter release from parasympathetic and sympathetic neur
ons through down-regulation of one or more subtypes of voltage-gated c
alcium channels. The results suggest chat antibody-mediated interferen
ce with specific ion channel function may also underlie autonomic dysf
unction occurring in other autoimmune diseases.